---
title: "HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290868300.md"
description: "HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy"
datetime: "2026-06-25T18:30:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290868300.md)
  - [en](https://longbridge.com/en/news/290868300.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290868300.md)
---

# HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy


### Related Stocks

- [BEAT.US](https://longbridge.com/en/quote/BEAT.US.md)

## Related News & Research

- [HeartBeam posts Q2 presentation outlining heart attack detection progress and initial commercial launch traction](https://longbridge.com/en/news/295840063.md)
- [HeartBeam Q2 FY26 net loss narrows to $5 million; SG&A expenses rise to $2.76 million](https://longbridge.com/en/news/295838239.md)
- [BEAT: Net loss narrowed, liquidity remains a concern, and strategic focus shifts to licensing and pilot studies](https://longbridge.com/en/news/295839360.md)
- [BEAT: Net loss and cash outflow declined as clinical and commercial milestones advanced, extending cash runway](https://longbridge.com/en/news/295839342.md)
- [HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidance](https://longbridge.com/en/news/295839639.md)